Get the StoQuant digest — free
Free StoQuant digest by email. No account needed.
See today's research picks.
RDY vs SNN — Stock Comparison
Compare RDY and SNN side-by-side on StoQuant: RDY Q-Score 50 vs SNN 25; analyst signal 78 vs 61. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.
Side-by-side snapshot
- RDY — Dr. Reddy's Laboratories Limited · Health Care · market cap $10.16B · Q-Score verdict Unrated (50.0) · analyst signal 78/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 86/100, technicals 31/100. Full RDY research.
- SNN — Smith & Nephew plc · Health Care · market cap $11.32B · Q-Score verdict Sell (25.0, grade D) · analyst signal 61/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: valuation 49/100, analyst consensus 35/100 · weakest signals: technicals 18/100. Full SNN research.
What you can compare
- Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
- Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
- Insider activity: Cluster scores and recent Form 4 buying.
- Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
- Strategic edges: Competitive moat and durable advantage analysis.
- Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
- Macro context: Market regime and sector rotation alignment.
Deep dive: RDY research · SNN research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →